Joel Block to Bone Neoplasms
This is a "connection" page, showing publications Joel Block has written about Bone Neoplasms.
Connection Strength
0.371
-
Chordoma and chondrosarcoma gene profile: implications for immunotherapy. Cancer Immunol Immunother. 2009 Mar; 58(3):339-49.
Score: 0.068
-
Targeting of cell survival genes using small interfering RNAs (siRNAs) enhances radiosensitivity of Grade II chondrosarcoma cells. J Orthop Res. 2007 Jun; 25(6):820-8.
Score: 0.063
-
Lysis of human chondrosarcoma cells by cytolytic T lymphocytes recognizing a MAGE-A3 antigen presented by HLA-A1 molecules. J Orthop Res. 2007 May; 25(5):678-84.
Score: 0.063
-
Hypoxia induces HIF-1alpha and VEGF expression in chondrosarcoma cells and chondrocytes. J Orthop Res. 2004 Nov; 22(6):1175-81.
Score: 0.053
-
Tenascin-C expression and distribution in cultured human chondrocytes and chondrosarcoma cells. J Orthop Res. 2002 Jul; 20(4):834-41.
Score: 0.045
-
Alterations in the regulatory pathway involving p16, pRb and cdk4 in human chondrosarcoma. J Orthop Res. 2001 Jan; 19(1):149-54.
Score: 0.041
-
Multidrug resistance-1 and p-glycoprotein in human chondrosarcoma cell lines: expression correlates with decreased intracellular doxorubicin and in vitro chemoresistance. J Orthop Res. 1999 Nov; 17(6):935-40.
Score: 0.037